A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...
The Food and Drug Administration on Friday granted emergency use authorization to a first-of-its-kind T-cell test, which is aimed at detecting previous coronavirus infections. Currently, antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback